The path to a rare disease diagnosis and treatment is often one marked by isolation, uncertainty, and constant self-advocacy. For marketers, researchers, and patient advocates, truly leading in the rare disease space requires a foundational understanding of this unique lived experience and a commitment to placing the patient and caregiver at the very center of every strategy.
This is the core of Health Union’s leadership in the rare disease community – a philosophy championed by Health Union President and COO, Lauren Lawhon, who emphasizes that true innovation begins with listening to the patient voice.
Individuals and families managing rare conditions navigate a reality distinct from those with more well-known conditions. Insights from Health Union’s Rare Disease In America study highlight the significant burden and the ways in which these patients and caregivers are forced to become “experts” in their own care.
Behaviors and Challenges:
Create your FREE account to continue reading and explore more expert insights on Pharma Media.
✅ Free. Fast. No commitment.